Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2026-02-20 @ 1:40 PM
Study NCT ID:
NCT01408160
Status:
TERMINATED
Last Update Posted:
2019-09-06
First Post:
2011-07-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Sponsor:
Albert Einstein College of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-26
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-12
First Submit QC Date:
None
Study First Post Date:
2011-08-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-04
Last Update Post Date:
2019-09-06
Last Update Post Date Type:
ACTUAL